Clinical Trials

Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 101 - 120 of 459 trials
Titlesort icon Investigator Disease(s)
A Phase I Study of Veliparib Given with Radiation Therapy to the Chest Wall and Lymph Nodes in Patients with Inflammatory or Recurrent Breast Cancer
[Protocol 12-215] 		Ho, Alice
A Phase I Study of Vemurafenib in Adolescents with Inoperable Stage IIIC/IV Melanoma with V600 BRAF Mutations
[Protocol 11-198] 		Pratilas, Christine
  • Melanoma
A Phase I Study of Whole Brain Radiation Therapy plus Sorafenib for Patients with Breast Cancer Brain Metastases
[Protocol 12-046] 		Seidman, Andrew
  • Brain Tumors, Metastatic
  • Breast Cancer
A Phase I Study of WT1-Sensitized T cells for Residual or Relapsed Leukemia after Allogeneic Hematopoietic Progenitor Cell Transplantation
[Protocol 07-055] 		O'Reilly, Richard
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Myelodysplastic Syndrome
A Phase I Study of WT1-Specific Donor-Derived T Cells in Patients with Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia after T-Cell-Depleted Allogeneic Stem Cell Transplantation
[Protocol 12-175] 		Koehne, Guenther
  • Hematology
    • Multiple Myeloma
A Phase I Study of WT1-Specific T Cells for the Treatment of Patients with Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Cancers
[Protocol 06-155] 		O'Cearbhaill, Roisin
  • Ovarian Cancer
A Phase I Trial of a New Vaccine (Globo-H-GM2-sTn-TF-Tn) for Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission
[Protocol 09-184] 		Sabbatini, Paul
  • Ovarian Cancer
A Phase I Trial of a Trivalent Vaccine with Escalating Doses of the Immunological Adjuvant OPT-821 Plus Oral ß-Glucan for High-Risk Neuroblastoma
[Protocol 05-075] 		Kushner, Brian
  • Neuroblastoma
A Phase I Trial of B-Cell Acute Lymphoblastic Leukemia Treated with Autologous T Cells Gene-Targeted to the B-Cell Antigen CD19
[Protocol 09-114] 		Davila, Marco
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase I Trial of Gemcitabine and Split-Dose Cisplatin plus Everolimus in Patients with Advanced Urothelial Cancer
[Protocol 10-106] 		Bajorin, Dean
  • Bladder Cancer
A Phase I Trial of NECTAR: Nelarabine, Etoposide, and Cyclophosphamide in Children with T-Cell Acute Lymphoblastic Leukemia
[Protocol 11-119] 		Trippett, Tanya
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase I-II Study of Dasatinib plus Paclitaxel in Patients with Metastatic Breast Cancer
[Protocol 08-122] 		Fornier, Monica
  • Breast Cancer
A Phase I/II Clinical Study of Vorinostat Plus Etoposide in Pediatric Patients with Refractory Solid Tumors
[Protocol 10-096] 		Trippett, Tanya
A Phase I/II Clinical Trial of Temsirolimus plus Neratinib for Patients with Metastatic HER2-Amplified or Triple-Negative Breast Cancer
[Protocol 10-005] 		Chandarlapaty, Sarat
  • Breast Cancer
A Phase I/II Study of Brentuximab (SGN-35) in Pediatric Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma or Hodgkin Lymphoma
[Protocol 11-210] 		Trippett, Tanya
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Phase I/II Study of Cabozantinib (XL184) in Patients with Recurrent or Persistent Myeloma
[Protocol 12-240] 		Giralt, Sergio
  • Hematology
    • Multiple Myeloma
A Phase I/II Study of Crizotinib and STA-9090 in ALK-Positive Lung Cancers
[Protocol 12-015] 		Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I/II Study of Eltrombopag During Consolidation Therapy in Adults with Acute Myeloid Leukemia in Complete Remission
[Protocol 12-229] 		Tallman, Martin
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase I/II Study of EPOCH Chemotherapy, Bortezomib, and Raltegravir for the Treatment of HTLV-1-Associated T-Cell Leukemia/Lymphoma
[Protocol 12-146] 		Noy, Ariela
  • Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I/II Study of Everolimus and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Non-Muscle-Invasive Bladder Cancer
[Protocol 10-165] 		Dalbagni, Guido
  • Bladder Cancer
On Our Blog